P38 MAPK Contributes to Resistance and Invasiveness of HER2- Overexpressing Breast Cancer

Current Medicinal Chemistry - United Arab Emirates
doi 10.2174/0929867320666131119155023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

MNK1 and MNK2 Regulation in HER2-overexpressing Breast Cancer Lines

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Effectiveness of Neoadjuvant Trastuzumab and Chemotherapy in HER2-overexpressing Breast Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2013English

Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells With Primary Trastuzumab Resistance

Anti-Cancer Agents in Medicinal Chemistry
Cancer ResearchMolecular MedicinePharmacology
2012English

HER2/ErbB2 Activates HSF1 and Thereby Controls HSP90 Clients Including MIF in HER2-overexpressing Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

Degradation of HER2/neu by ANT2 shRNA Suppresses Migration and Invasiveness of Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Her2 Cross Talk and Therapeutic Resistance in Breast Cancer

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2008English

Trastuzumab-Dm1: A Review of the Novel Immuno-Conjugate for HER2- Overexpressing Breast Cancer

The Open Breast Cancer Journal
2009English

The Role of HER2 in Early Breast Cancer Metastasis and the Origins of Resistance to HER2-targeted Therapies

Experimental and Molecular Pathology
Forensic MedicinePathologyClinical BiochemistryMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy